Using AI to screen infants for hip dysplasia
Official title: Artificial Intelligence Augmented Ultrasound for Developmental Dysplasia of the Hip: a Validity Study
Run by Murdoch Childrens Research Institute · NCT06647225 · Data updated 2026-11-12
This study is testing if using AI with ultrasounds can help doctors find hip dysplasia in infants better than regular ultrasounds.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 4 Weeks to 20 Weeks |
| Sex | All |
| Enrollment | 240 (estimated) |
| Sponsor | Murdoch Childrens Research Institute Academic / other |
| Locations | 1 site (Parkville, Victoria) |
| Status | Recruiting |
| Started | December 6, 2024 |
| Main results expected | November 2026 |
| Study ends | November 2026 |
| Registry record updated | April 8, 2026 |
| Trial ID | NCT06647225 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are infants aged 4-20 weeks who are attending The Royal Children's Hospital for a potential diagnosis of hip dysplasia.
✕Probably not a fit
Patients currently receiving treatment for hip dysplasia will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the accuracy of an artificial intelligence-enhanced ultrasound in screening for developmental dysplasia of the hip (DDH) in infants. Researchers will compare the results of AI-assisted ultrasounds with standard ultrasound measures to determine if the AI approach can improve detection rates. Additionally, the study will gather feedback from parents regarding their experiences with the ultrasound procedure. Participants will undergo an extra ultrasound during their scheduled appointment and complete a questionnaire about the process.
Why it matters
Potential benefit: If successful, this approach could lead to more accurate and accessible screening for hip dysplasia in infants, potentially reducing the number of undetected cases.
How similar studies have gone: While some studies have explored AI in medical imaging, this specific application for hip dysplasia screening is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Enrolled in the VicHip study * Is 4-20 weeks of age at enrolment * Is attending The Royal Children's Hospital for the purpose of the potential diagnosis of DDH * Has a diagnostic (standard) hip ultrasound on the day of their out-patient appointment * Has a legally acceptable representative capable of understanding the informed consent document and providing consent on the participant's behalf. Exclusion Criteria: Participants will be excluded from enrolment if: • They are currently receiving treatment for DDH
Where it's running
-
Royal Children's Hospital
Parkville, Victoria, Australia Recruiting
Study contacts
- Principal investigator: Leo T Donnan — Murdoch Childrens Research Institute
- Study coordinator: Natalie K Hyde, BBiomedSc (Hons), PhD
- Email: natalie.hyde@mcri.edu.au
- Phone: 61 3 9936 6246
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Collarless Actis hip stem for cementless hip replacement in Asian patients
This study tests how well a collarless Actis hip stem works in adults undergoing primary hip replacement, focusing on outcomes over five years in an East Asian population.
-
Speech therapy for kids with rare genetic conditions and childhood apraxia of speech
This study tests whether 4 weeks of targeted speech therapy can improve speech accuracy in children with childhood apraxia of speech and rare genetic conditions, using one treatment approach per child.
-
Stop antibiotics early when symptoms stop in kids after IV treatment
This trial tests whether stopping oral antibiotics as soon as symptoms disappear is just as effective as finishing the prescribed course for kids who had IV antibiotics for cellulitis, UTI, LRTI, or lymphadenitis.
-
Impact of Lung Pressure Levels During MIST on Preterm Babies’ Lung Aeration
This study tests whether applying a lung recruitment maneuver before minimally invasive surfactant therapy helps preterm infants breathe more easily.
-
Long-term follow-up after 18 months of oral immunotherapy for peanut, egg, or milk allergy (5–15 years later)
This follow-up will see if children and young people who completed an 18-month oral immunotherapy for peanut, egg, or milk allergy still have changes in allergy tests and better quality of life 5–15 years later.
-
Exercise and activity tracking during early treatment for children with ALL to prevent muscle loss and frailty
This pilot test tries a home-based physical activity and strengthening program with a Fitbit for children aged 5–17 who show early muscle weakness after starting treatment for acute lymphoblastic leukaemia to see if it prevents muscle loss and improves strength compared with usual care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.